SOPHiA GENETICS News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.11.24	Ausblick: SOPHiA GENETICS SA zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
10.09.24	SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally (RTTNews)
05.08.24	Ausblick: SOPHiA GENETICS SA präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
06.05.24	Ausblick: SOPHiA GENETICS SA legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
21.12.23	Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders (PR Newswire)
07.12.23	SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings (PR Newswire)
30.11.23	SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes (PR Newswire)
28.11.23	SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino (PR Newswire)
17.11.23	The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS (PR Newswire)
07.11.23	BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ (PR Newswire)
07.11.23	BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ (PR Newswire)
06.11.23	Ausblick: SOPHiA GENETICS SA zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
18.10.23	SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care (PR Newswire)
29.09.23	Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders (PR Newswire)
13.09.23	Laboratorio Curie Expands Relationship with SOPHiA GENETICS (PR Newswire)
07.09.23	SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform (PR Newswire)
30.08.23	CHU Bordeaux is live on SOPHiA GENETICS (PR Newswire)
22.08.23	SOPHiA GENETICS Expands Relationship with Gustave Roussy (PR Newswire)
17.08.23	A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM™ Platform (PR Newswire)
08.08.23	Tulane University School of Medicine Uses SOPHiA GENETICS to Advance Research of Blood Cancers (PR Newswire)
07.08.23	Ausblick: SOPHiA GENETICS SA stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
25.07.23	SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2023 on August 8, 2023 (PR Newswire)
13.07.23	SOPHiA GENETICS Announces Gruppo Centro Servizi Medici (CSM) is Live on the SOPHiA DDM™ Platform (PR Newswire)
07.07.23	Centre Hospitalier de Bastia is Live on SOPHiA GENETICS (PR Newswire)
26.06.23	SOPHiA GENETICS Publishes Results of 2023 Annual General Meeting (PR Newswire)
22.06.23	Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform (PR Newswire)
15.06.23	NOMAD Genetics is Live on the SOPHiA GENETICS Platform (PR Newswire)
02.06.23	SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research (PR Newswire)
31.05.23	SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors (PR Newswire)
24.05.23	Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research (PR Newswire)
16.05.23	Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing (PR Newswire)
15.05.23	Dasa Expands Its Capabilities with SOPHiA GENETICS (PR Newswire)
06.03.23	Ausblick: SOPHiA GENETICS SA präsentiert Quartalsergebnisse (finanzen.net)
07.11.22	Ausblick: SOPHiA GENETICS SA zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
01.11.22	SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis (PR Newswire)
24.10.22	Erste Schätzungen: SOPHiA GENETICS SA legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
21.09.22	SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event (PR Newswire)
08.08.22	Ausblick: SOPHiA GENETICS SA verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
25.07.22	Erste Schätzungen: SOPHiA GENETICS SA stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
15.06.22	SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting (PR Newswire)
15.06.22	SOPHiA GENETICS Publishes Environmental, Social and Governance Impact Summary (PR Newswire)
06.06.22	SOPHiA GENETICS Provides an Update on its DEEP-Lung-IV Multimodal Clinical Study at ASCO 2022 (PR Newswire)
09.05.22	Ausblick: SOPHiA GENETICS SA stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
05.05.22	SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors (PR Newswire)
26.04.22	SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform (PR Newswire)
25.04.22	Erste Schätzungen: SOPHiA GENETICS SA veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
14.03.22	SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research (PR Newswire)
09.03.22	SOPHiA GENETICS HRD Solution Adopted in Asia Pacific (PR Newswire)
24.02.22	SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu SOPHiA GENETICS SA

Aktien Top/Flop

Meistgelesene Nachrichten